YOUNG KWON - 15 Oct 2021 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role: Director
Signature: /s/ Young T. Kwon, by Brian Lenz as attorney-in-fact
Issuer symbol: ADMA
Transactions as of: 15 Oct 2021
Net transactions value: $0
Form type: 4
Filing time: 18 Oct 2021, 18:21:17 UTC
Next filing: 26 Oct 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ADMA	Stock Option (right to buy)	Award	$0	+93,500		$0.000000	93,500	15 Oct 2021	Common Stock	93,500	$1.10	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the grant of a stock option to purchase 93,500 shares of common stock, $0.0001 par value per share ("Common Stock") of ADMA Biologics, Inc. The shares of Common Stock underlying the stock option will vest in 12 equal monthly installments, becoming fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service on the applicable vesting date.

Content

Reflects the grant of a stock option to purchase 93,500 shares of common stock, $0.0001 par value per share ("Common Stock") of ADMA Biologics, Inc. The shares of Common Stock underlying the stock option will vest in 12 equal monthly installments, becoming fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service on the applicable vesting date.